LG CNS unveiled an agentic artificial intelligence (AI)-powered development platform designed to automate the entire cycle of ...
Central nervous system (CNS) toxicity accounts for 25% of safety failures across drug discovery and development, yet it is rarely detected during standard GLP toxicology studies 1. Seizure risk ...
Vect-Horus has a clinical-phase solution to a key drug development challenge: crossing the blood–brain barrier (BBB). By targeting receptors on the barrier, Vect-Horus is empowering partners such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results